ampicillin has been researched along with cefminox in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Inouye, S; Miyata, A; Tsuruoka, T; Yoshida, T | 1 |
Arai, S; Ishii, T; Kamiya, H; Kawamura, R; Sakurai, M | 1 |
3 other study(ies) available for ampicillin and cefminox
Article | Year |
---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
[Lytic action of cefminox against slowly growing bacteria].
Topics: Ampicillin; Bacteriolysis; Cefmetazole; Cephamycins; Dose-Response Relationship, Drug; Escherichia coli; Penicillins; Time Factors | 1995 |
The in vivo and in vitro postantibiotic effect of aminoglycosides using a clinically isolated micro-organism.
Topics: Abscess; Adolescent; Ampicillin; Anti-Bacterial Agents; Cephamycins; Cloxacillin; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Gentamicins; Humans; Male; Serratia Infections; Serratia marcescens | 1993 |